|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8520 EUR | -1.39% |
|
+0.24% | -37.54% |
| 06-18 | AB Science Secures US Patent for Prostate Cancer Therapy | MT |
| 06-18 | AB Science Secures New U.S. Patent for Masitinib |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 318B | |||||
| 72.22B | |||||
| 8.89B | |||||
| 8.25B | |||||
| 4.23B |
- Stock Market
- Stocks
- AB Stock
- A8D Stock
- Charts AB Science
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
